semaglutide action as a Cornerstone Therapy in Obesity: Clinical and Pharmacological Insights Potential action mechanisms of semaglutide

It works through the bodys natural regulatory system, supporting a more physiologic release pattern

Gastrointestinal side effects are common during the first weeks of semaglutide therapynausea, constipation, or reduced appetite

More clinical trials are needed to confirm the benefits and understand the long-term effects of semaglutide in asthma patients

Among incretin hormones, GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) play the largest roles

This dual activation may provide additional metabolic benefits for patients with insulin resistance or metabolic inefficiency, though response depends on individual genetics and baseline metabolic function

Clinical trials comparing the two drugs directly are already underway at Eli Lilly, and that data will eventually inform switching protocols